California Public Employees Retirement System
SUPN icon

California Public Employees Retirement System’s Supernus Pharmaceuticals SUPN Stock Holding History

California Public Employees Retirement System’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-99,700
Closed -$2.61M – 2769
2021
Q1 		$2.61M Sell
99,700
-14,714
-13% -$412K ﹤0.01% 1846
2020
Q4 		$2.88M Sell
114,414
-1,227
-1% -$26.4K ﹤0.01% 1767
2020
Q3 		$2.41M Buy
115,641
+4,460
+4% +$101K ﹤0.01% 1714
2020
Q2 		$2.64M Sell
111,181
-242
-0.2% -$5.35K ﹤0.01% 1625
2020
Q1 		$2M Sell
111,423
-41,958
-27% -$882K ﹤0.01% 1596
2019
Q4 		$3.64M Buy
153,381
+49,908
+48% +$1.21M ﹤0.01% 1659
2019
Q3 		$2.84M Buy
103,473
+27,961
+37% +$828K ﹤0.01% 1662
2019
Q2 		$2.5M Sell
75,512
-3,392
-4% -$116K ﹤0.01% 1571
2019
Q1 		$2.77M Buy
78,904
+3,333
+4% +$124K ﹤0.01% 1564
2018
Q4 		$2.51M Sell
75,571
-6,000
-7% -$258K ﹤0.01% 1558
2018
Q3 		$4.11M Buy
81,571
+9,014
+12% +$445K 0.01% 1433
2018
Q2 		$4.34M Buy
72,557
+20,496
+39% +$1.06M 0.01% 1384
2018
Q1 		$2.38M Sell
52,061
-7,108
-12% -$297K ﹤0.01% 1793
2017
Q4 		$2.36M Buy
59,169
+12,079
+26% +$477K ﹤0.01% 1846
2017
Q3 		$1.88M Buy
47,090
+8,190
+21% +$354K ﹤0.01% 1951
2017
Q2 		$1.68M Hold
38,900
– – ﹤0.01% 1963
2017
Q1 		$1.22M Sell
38,900
-1,700
-4% -$45.6K ﹤0.01% 2174
2016
Q4 		$1.02M Hold
40,600
– – ﹤0.01% 2301
2016
Q3 		$1M Sell
40,600
-25,800
-39% -$584K ﹤0.01% 2340
2016
Q2 		$1.35M Sell
66,400
-300
-0.4% -$5.32K ﹤0.01% 2156
2016
Q1 		$1.02M Sell
66,700
-12,700
-16% -$166K ﹤0.01% 2323
2015
Q4 		$1.07M Sell
79,400
-29,000
-27% -$449K ﹤0.01% 2336
2015
Q3 		$1.52M Buy
108,400
+16,400
+18% +$305K ﹤0.01% 2099
2015
Q2 		$1.56M Buy
92,000
+42,700
+87% +$608K ﹤0.01% 2217
2015
Q1 		$425K Hold
49,300
– – ﹤0.01% 3068
2014
Q4 		$425K Hold
49,300
– – ﹤0.01% 3068
2014
Q3 		$428K Hold
49,300
– – ﹤0.01% 3043
2014
Q2 		$540K Hold
49,300
– – ﹤0.01% 2962
2014
Q1 		$432K Buy
+49,300
New +$454K ﹤0.01% 3045
2013
Q4 		– Sell
-100
Closed -$1K – 4032
2013
Q3 		$1K Hold
100
– – ﹤0.01% 3971
2013
Q2 		$1K Buy
+100
New +$589 ﹤0.01% 3985

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

California Public Employees Retirement System's SUPN Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Supernus Pharmaceuticals (SUPN) in Q2 2021, closing a stake of 99,700 shares — an estimated $2.61M sold.

California Public Employees Retirement System first reported a position in SUPN in Q2 2013 and held it in 31 quarters. The position peaked at $4.34M in Q2 2018. 226 funds tracked by Wall St. Rank hold SUPN as of Q2 2021.

  • California Public Employees Retirement System reported no remaining Supernus Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 99,700 Supernus Pharmaceuticals shares in Q2 2021, an estimated $2.61M.
  • California Public Employees Retirement System first reported a position in Supernus Pharmaceuticals in Q2 2013 and held it in 31 quarters.
  • California Public Employees Retirement System's Supernus Pharmaceuticals position peaked at $4.34M in Q2 2018.
  • 226 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.